877
Views
19
CrossRef citations to date
0
Altmetric
The Västerbotten Intervention Programme

A reversal of decreasing trends in population cholesterol levels in Västerbotten County, Sweden

, , &
Article: 10367 | Received 04 Oct 2011, Accepted 28 Feb 2012, Published online: 23 Mar 2012

References

  • World Health Organization. The Global Burden of Disease: 2004 Update. Geneva: World Health Organization. 2008.
  • Fox CS, Evans JC, Larson MG, Kannel WB, Levy D. Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: the Framingham Heart Study. Circulation. 110; 2004: 522–7.
  • Truelsen T, Mahonen M, Tolonen H, Asplund K, Bonita R, Vanuzzo D. Trends in stroke and coronary heart disease in the WHO MONICA Project. Stroke. 2003; 34: 1346–52.
  • Taylor R, Dobson A, Mirzaei M. Contribution of changes in risk factors to the decline of coronary heart disease mortality in Australia over three decades. Eur J Cardiovasc Prev Rehabil. 2006; 13: 760–8.
  • Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H, et al.. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet. 2000; 355: 675–87.
  • Sweden National Board of Health and Welfare. Statistics – health and medical care: causes of death 2010. Stockholm: Sweden National Board of Health and Welfare. 2011.
  • Durrington P. Dyslipidaemia. Lancet. 2003; 362: 717–31.
  • Farzadfar F, Finucane MM, Danaei G, Pelizzari PM, Cowan MJ, Paciorek CJ, et al.. National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants. Lancet. 3 77; 2011: 578–86.
  • World Health Organization. MONICA Monograph and Multimedia Sourcebook. Geneva: World Health Organization. 2005.
  • Eriksson M, Holmgren L, Janlert U, Jansson JH, Lundblad D, Stegmayr B, et al.. Large improvements in major cardiovascular risk factors in the population of northern Sweden: the MONICA study 1986–2009. J Intern Med. 269; 2011: 219–31.
  • Statistics Sweden. Causes of death 1985. Stockholm: National Central Bureau of Statistics. 1987.
  • Weinehall L, Hellsten G, Boman K, Hallmans G. Prevention of cardiovascular disease in Sweden: the Norsjo community intervention programme –motives, methods and intervention components. Scand J Public Health Suppl. 2001; 56: 13–20.
  • Norberg M, Wall S, Boman K, Weinehall L. The Västerbotten Intervention Programme: background, design and implications. Global Health Action2010; 3: 10.3402/gha.v5i0.10367.
  • von Schenck H, Treichl L, Tilling B, Olsson AG. Laboratory and field evaluation of three desktop instruments for assay of cholesterol and triglyceride. Clin Chem. 1987; 33: 1230–2.
  • Norberg M, Lindvall K, Stenlund H, Lindahl B. The obesity epidemic slows among the middle-aged population in Sweden while the socioeconomic gap widens. Global Health Action. 2010; 3: 5149 - 10.3402/gha.v5i0.10367.
  • Norberg M, Lundqvist G, Nilsson M, Gilljam H, Weinehall L. Changing patterns of tobacco use in a middle-aged population: the role of snus, gender, age, and education. Global Health Action. 2011; 4: 5613 - 10.3402/gha.v5i0.10367.
  • Lindahl B, Stenlund H, Norberg M. Increasing glucose concentrations and prevalence of diabetes mellitus in northern Sweden, 1990–2007. Global Health Action. 2010; 3: 5222 - 10.3402/gha.v5i0.10367.
  • Ng N, Soderman K, Norberg M, Ohman A. Increasing physical activity, but persisting social gaps among middle-aged people: trends in Northern Sweden from 1990 to 2007. Global Health Action. 2011; 4: 6347 - 10.3402/gha.v5i0.10367.
  • StataCorp LP. Stata 11.2. TXUSA; 2009
  • Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, et al.. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011; 123: 2292–333.
  • Mann J, Nye ER. Fad diets in Sweden, of all places. Lancet. 2009; 374: 767–9.
  • SBU. Mat vid diabetes: en systematisk litteraturöversikt (in Swedish). SBU the Swedish Council on Health Technology Assessment. Stockholm, 2010
  • Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Saturated fat, carbohydrate, and cardiovascular disease. Am J Clin Nutr. 2010; 91: 502–9.
  • Pramparo P, Schargrodsky H, Boissonnet C, Champagne B, Silva S, Acevedo M, et al.. Cardiovascular risk factors for heart disease and stroke in women by age and time since menopause, in seven Latin American cities: the CARMELA study. CVD Prevent Control. 2008; 3: 181–9.
  • de Aloysio D, Gambacciani M, Meschia M, Pansini F, Bacchi Modena A, Bolis PF, et al.. The effect of menopause on blood lipid and lipoprotein levels. The Icarus Study Group. Atherosclerosis. 1999; 147: 147–53.
  • Agrinier N, Cournot M, Dallongeville J, Arveiler D, Ducimetiere P, Ruidavets JB, et al.. Menopause and modifiable coronary heart disease risk factors: a population based study. Maturitas. 2010; 65: 237–43.
  • Hak AE, Witteman JC, Hugens W, Keyzer JJ, Pop VJ, Uitterlinden AG, et al.. The increase in cholesterol with menopause is associated with the apolipoprotein E genotype. A population-based longitudinal study. Atherosclerosis. 2004; 175: 169–76.
  • National Cholesterol Education Program (NCEP). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002; 106: 3143–421.
  • Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, et al.. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007; 370: 1829–39.